Tiago Girao - 26 Jun 2026 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Reporting relationship: Chief Financial Officer
Issuer ticker: IMVT
Reported as of: 26 Jun 2026
Net transaction value: -$384,600
SEC form: 4
Accepted by SEC: 26 Jun 2026, 19:44:00 UTC
Prior SEC filing: 24 Apr 2026
Next SEC filing: 24 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Tiago Girao

Key filing fact

Tiago Girao filed Form 4 for Immunovant, Inc. (IMVT) on 26 Jun 2026.

Key facts

This page summarizes Tiago Girao's Form 4 filing for Immunovant, Inc. (IMVT).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 26 Jun 2026, 19:44.

Change

Previous filing in this sequence was filed on 24 Apr 2026.
Current net transaction value: -$384,600.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001618670 Primary reporting owner

Girao Tiago

Relationship: Chief Financial Officer
Address: C/O IMMUNOVANT, INC., 1000 PARK FORTY PLAZA, SUITE 210, DURHAM
Signature: /s/ Tiago Girao
Signature date: 26 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMVT transaction

Common Stock

Options Exercise

Transaction value
Shares: +10,000
Change %: +4%
Price: $15.90^*
Shares after: 257,596
Date: 26 Jun 2026
Ownership: Direct

IMVT transaction

Common Stock

Sale

Transaction value: $384,600
Shares: -10,000
Change %: -3.9%
Price: $38.46
Shares after: 247,596
Date: 26 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMVT transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -10,000
Change %: -3.4%
Price: $0.000000^*
Shares after: 283,505
Date: 26 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $15.90
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 - $38.90 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Footnote F2

Award of stock options to purchase Common Shares with a grant date of May 1, 2025. The shares underlying the option vest as to 25% on April 21, 2026, with the remainder vesting in 12 successive substantially equal quarterly installments over three years thereafter, subject to the Reporting Person's continued service to the Issuer as of such date.